Table 8 Results of the MTT assay for MM-compounds documented in the literature. The cytotoxic properties of compounds were documented across various cancer cell lines, including BxPC-3 (pancreatic adenocarcinoma), PC-3 (prostate cancer), HeLa (cervical cancer), and DLD1/HCT116/HT29 (colorectal adenocarcinoma), as well as normal cells such as human lung fibroblasts (WI-38) and human peripheral blood mononuclear cells (PBMCs). The data were acquired following a 72-hour incubation of the cells with investigated sulfonamides (or 24 hours as denoted by the (#) symbol). N/D – not-determined; * - not-published data. Based on⁷⁶

From: Synthesis, anticancer evaluation, and electrochemical investigation of new chiral pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides